AstraZeneca PLC is 154.7x more valuable than Nurix Therapeutics, Inc. by market capitalization ($286.27 B vs $1.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NRIX | AZN |
|---|---|---|
| Market cap | $1.85 B | $286.27 B |
| US-listed rank | #2152 | #45 |
| Revenue (latest FY) | $83.98M | - |
| Net income (latest FY) | -$264.46M | - |
| Net margin | -314.9% | - |
| SEC filings | 511 | 1,004 |
AstraZeneca PLC is 154.7x more valuable than Nurix Therapeutics, Inc. by market capitalization ($286.27 B vs $1.85 B).
Full pages: Nurix Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.